Literature DB >> 33467548

Bacteriophage Cocktail-Mediated Inhibition of Pseudomonas aeruginosa Biofilm on Endotracheal Tube Surface.

Viviane C Oliveira1,2, Ana P Macedo2, Luís D R Melo3, Sílvio B Santos3, Paula R S Hermann1,4, Cláudia H Silva-Lovato2, Helena F O Paranhos2, Denise Andrade1, Evandro Watanabe1,5.   

Abstract

Although different strategies to control biofilm formation on endotracheal tubes have been proposed, there are scarce scientific data on applying phages for both removing and preventing Pseudomonas aeruginosa biofilms on the device surface. Here, the anti-biofilm capacity of five bacteriophages was evaluated by a high content screening assay. We observed that biofilms were significantly reduced after phage treatment, especially in multidrug-resistant strains. Considering the anti-biofilm screens, two phages were selected as cocktail components, and the cocktail's ability to prevent colonization of the endotracheal tube surface was tested in a dynamic biofilm model. Phage-coated tubes were challenged with different P. aeruginosa strains. The biofilm growth was monitored from 24 to 168 h by colony forming unit counting, metabolic activity assessment, and biofilm morphology observation. The phage cocktail promoted differences of bacterial colonization; nonetheless, the action was strain dependent. Phage cocktail coating did not promote substantial changes in metabolic activity. Scanning electron microscopy revealed a higher concentration of biofilm cells in control, while tower-like structures could be observed on phage cocktail-coated tubes. These results demonstrate that with the development of new coating strategies, phage therapy has potential in controlling the endotracheal tube-associated biofilm.

Entities:  

Keywords:  Pseudomonas aeruginosa; bacteriophage; biofilm; endotracheal tube

Year:  2021        PMID: 33467548      PMCID: PMC7830274          DOI: 10.3390/antibiotics10010078

Source DB:  PubMed          Journal:  Antibiotics (Basel)        ISSN: 2079-6382


  43 in total

Review 1.  Phage cocktails and the future of phage therapy.

Authors:  Benjamin K Chan; Stephen T Abedon; Catherine Loc-Carrillo
Journal:  Future Microbiol       Date:  2013-06       Impact factor: 3.165

2.  A clinical assessment of the Mucus Shaver: a device to keep the endotracheal tube free from secretions.

Authors:  Lorenzo Berra; Andrea Coppadoro; Edward A Bittner; Theodor Kolobow; Patrice Laquerriere; Joshua R Pohlmann; Simone Bramati; Joel Moss; Antonio Pesenti
Journal:  Crit Care Med       Date:  2012-01       Impact factor: 7.598

3.  Pros and cons of phage therapy.

Authors:  Catherine Loc-Carrillo; Stephen T Abedon
Journal:  Bacteriophage       Date:  2011-03

4.  Eradication of endotracheal tube biofilm by nebulised gentamicin.

Authors:  C G Adair; S P Gorman; L M Byers; D S Jones; B Feron; M Crowe; H C Webb; G J McCarthy; K R Milligan
Journal:  Intensive Care Med       Date:  2002-03-06       Impact factor: 17.440

5.  Endotracheal tubes coated with antiseptics decrease bacterial colonization of the ventilator circuits, lungs, and endotracheal tube.

Authors:  Lorenzo Berra; Lorenzo De Marchi; Zu-Xi Yu; Patrice Laquerriere; Andrea Baccarelli; Theodor Kolobow
Journal:  Anesthesiology       Date:  2004-06       Impact factor: 7.892

6.  Endotracheal tube biofilm translocation in the lateral Trendelenburg position.

Authors:  Gianluigi Li Bassi; Laia Fernandez-Barat; Lina Saucedo; Valeria Giunta; Joan Daniel Marti; Otavio Tavares Ranzani; Eli Aguilera Xiol; Montserrat Rigol; Ignasi Roca; Laura Muñoz; Nestor Luque; Mariano Esperatti; Maria Adela Saco; Jose Ramirez; Jordi Vila; Miguel Ferrer; Antoni Torres
Journal:  Crit Care       Date:  2015-02-27       Impact factor: 9.097

7.  Endotracheal Tube Biofilm and its Impact on the Pathogenesis of Ventilator-Associated Pneumonia.

Authors:  Olguța Diaconu; Ianis Siriopol; Laura Iulia Poloșanu; Ioana Grigoraș
Journal:  J Crit Care Med (Targu Mures)       Date:  2018-04-01

8.  The challenge of ventilator-associated pneumonia diagnosis in COVID-19 patients.

Authors:  Bruno François; Pierre-François Laterre; Charles-Edouard Luyt; Jean Chastre
Journal:  Crit Care       Date:  2020-06-05       Impact factor: 9.097

Review 9.  Pharmacological limitations of phage therapy.

Authors:  Anders S Nilsson
Journal:  Ups J Med Sci       Date:  2019-11-14       Impact factor: 2.384

View more
  5 in total

1.  Assessment of Phage-Mediated Inhibition and Removal of Multidrug-Resistant Pseudomonas aeruginosa Biofilm on Medical Implants.

Authors:  Stephen Amankwah; Mekonen Adisu; Kasahun Gorems; Kedir Abdella; Tesfaye Kassa
Journal:  Infect Drug Resist       Date:  2022-05-31       Impact factor: 4.177

Review 2.  Phage therapy of wound-associated infections.

Authors:  Anna Zyman; Andrzej Górski; Ryszard Międzybrodzki
Journal:  Folia Microbiol (Praha)       Date:  2022-01-13       Impact factor: 2.099

Review 3.  Antimicrobial Coating: Tracheal Tube Application.

Authors:  Xuemeng Chen; Xiaomei Ling; Gaowang Liu; Jinfang Xiao
Journal:  Int J Nanomedicine       Date:  2022-03-29

4.  Characterization and anti-biofilm activity of bacteriophages against urinary tract Enterococcus faecalis isolates.

Authors:  Doaa M El-Atrees; Reham F El-Kased; Ahmad M Abbas; Mahmoud A Yassien
Journal:  Sci Rep       Date:  2022-07-29       Impact factor: 4.996

Review 5.  Pathogenesis of the Pseudomonas aeruginosa Biofilm: A Review.

Authors:  Felipe Francisco Tuon; Leticia Ramos Dantas; Paula Hansen Suss; Victoria Stadler Tasca Ribeiro
Journal:  Pathogens       Date:  2022-02-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.